Search
for
Sort by
Research 241–270 of 1000+
- Considerations for the Treatment Strategy of Relapse After Tofacitinib Therapy in Alopecia Areata
- Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b–3 trial
- Predictors and Management of Inadequate Response to JAK Inhibitors in Alopecia Areata
- Perceived Stigma and Mental Health Disorders Among Adults With Alopecia Areata Living in Japan
- Efficacy of Baricitinib in Patients with Various Degrees of Alopecia Areata Severity: Post-Hoc Analysis from BRAVE AA1 and BRAVE AA2
- Circulating MicroRNA Signatures in Severe Alopecia Areata: Diagnostic Discrimination, Pathway Analysis, and Therapeutic Implications
- Real-life effectiveness and safety of baricitinib in 17 Japanese patients with alopecia areata: a 60-week single center study
- A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results
- The burden of alopecia areata: A scoping review focusing on quality of life, mental health and work productivity
- Autophagy and alopecia areata: is there a link?
- Effectiveness and safety of baricitinib in patients with moderate‐to‐severe refractory alopecia areata in real world: An open‐label, single‐center study
- Overlapping features of atopic dermatitis and alopecia areata: from pathogenesis to treatment
- Abrocitinib Improved Dupilumab-Resistant Severe Atopic Dermatitis with Comorbid Mild Alopecia Areata in a 12-Year-Old Boy: A Case Report with 1-Year Follow-Up
- Beyond health-related quality of life: initial psychometric validation of a new scale for addressing the gap in assessing the full range of alopecia areata psychosocial burden
- Quality of life, psychosocial difficulties and bullying in paediatric patients with alopecia areata: a European cross-sectional study
- Quality of Life Assessment in Male Patients with Androgenetic Alopecia: Result of a Prospective, Multicenter Study
- Reversal of alopecia areata, osteoporosis follow treatment with activation of Tgr5 in mice
- RETRACTED: Interleukin‐33 links asthma to alopecia areata: Mendelian randomization and mediation analysis
- Acupuncture for treating alopecia areata: A systematic review and meta-analysis
- Importance of alexithymia on anxiety and depression in alopecia areata: a cohort study
- Evaluating Current and Emergent JAK Inhibitors for Alopecia Areata: A Narrative Review
- The Effectiveness and Safety of Three Treatment Regimens of Topical Minoxidil 5.0%, Betamethasone 0.064% w/w, and Castor and Jojoba Oils for Alopecia Areata: A Multicenter Cohort Study
- Efficacy and Tolerability of Brevilin-A, a Natural JAK Inhibitor, in Pediatric Alopecia Areata: A Case Series
- Comparative Efficacy and Safety of Baricitinib Against Traditional Therapies in Severe Alopecia Areata: A Retrospective Cohort Study
- Altered hypothalamus functional connectivity and psychological stress in patients with alopecia areata
- Assessing Alopecia Areata Management in Poland: Challenges in Medical Practices and Patient Care
- Systemic Treatment of Moderate to Severe Alopecia Areata in Adults: Updated Australian Expert Consensus Statement
- Two‐dimensional planimetry for alopecia areata severity evaluation compared with severity of alopecia tool: A pilot study
- Forging the Future: 2018 Alopecia Areata Research Summit Summary Report
- Sustained hair regrowth with continued ritlecitinib treatment through week 48 in patients with alopecia areata with or without early target responses: Post hoc analysis of the ALLEGRO phase 2b/3 trial